M&R Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.6M | Buy |
1,802
+44
| +3% | +$39.6K | 0.35% | 49 |
|
|
2024
Q2 | $1.59M | Sell |
1,758
-14
| -0.8% | -$11.2K | 0.38% | 48 |
|
|
2024
Q1 | $1.38M | Sell |
1,772
-605
| -25% | -$431K | 0.34% | 49 |
|
|
2023
Q4 | $1.39M | Buy |
2,377
+24
| +1% | +$14K | 0.35% | 48 |
|
|
2023
Q3 | $1.26M | Sell |
2,353
-107
| -4% | -$55.1K | 0.35% | 49 |
|
|
2023
Q2 | $1.15M | Buy |
2,460
+1
| +0% | +$419 | 0.3% | 51 |
|
|
2023
Q1 | $845K | Sell |
2,459
-226
| -8% | -$76.2K | 0.24% | 63 |
|
|
2022
Q4 | $982K | Buy |
2,685
+406
| +18% | +$144K | 0.27% | 57 |
|
|
2022
Q3 | $737K | Sell |
2,279
-45
| -2% | -$14.3K | 0.21% | 66 |
|
|
2022
Q2 | $753K | Buy |
2,324
+86
| +4% | +$25.8K | 0.2% | 71 |
|
|
2022
Q1 | $641K | Sell |
2,238
-4
| -0.2% | -$1.03K | 0.14% | 89 |
|
|
2021
Q4 | $619K | Buy |
2,242
+81
| +4% | +$20.5K | 0.13% | 88 |
|
|
2021
Q3 | $499K | Buy |
2,161
+200
| +10% | +$49.4K | 0.11% | 97 |
|
|
2021
Q2 | $450K | Buy |
1,961
+120
| +7% | +$24.1K | 0.1% | 102 |
|
|
2021
Q1 | $343K | Hold |
1,841
| – | – | 0.09% | 114 |
|
|
2020
Q4 | $310K | Sell |
1,841
-250
| -12% | -$37.3K | 0.07% | 132 |
|
|
2020
Q3 | $309K | Hold |
2,091
| – | – | 0.08% | 128 |
|
|
2020
Q2 | $343K | Sell |
2,091
-100
| -5% | -$15.3K | 0.09% | 120 |
|
|
2020
Q1 | $303K | Hold |
2,191
| – | – | 0.09% | 131 |
|
|
2019
Q4 | $287K | Hold |
2,191
| – | – | 0.06% | 153 |
|
|
2019
Q3 | $245K | Hold |
2,191
| – | – | 0.06% | 161 |
|
|
2019
Q2 | $242K | Hold |
2,191
| – | – | 0.05% | 164 |
|
|
2019
Q1 | $262K | Sell |
2,191
-200
| -8% | -$24.3K | 0.06% | 162 |
|
|
2018
Q4 | $276K | Hold |
2,391
| – | – | 0.07% | 153 |
|
|
2018
Q3 | $256K | Hold |
2,391
| – | – | 0.06% | 170 |
|
|
2018
Q2 | $204K | Hold |
2,391
| – | – | 0.05% | 174 |
|
|
2018
Q1 | $184K | Sell |
2,391
-50
| -2% | -$4.03K | 0.04% | 187 |
|
|
2017
Q4 | $206K | Sell |
2,441
-50
| -2% | -$4.25K | 0.05% | 177 |
|
|
2017
Q3 | $213K | Hold |
2,491
| – | – | 0.05% | 176 |
|
|
2017
Q2 | $202K | Hold |
2,491
| – | – | 0.05% | 185 |
|
|
2017
Q1 | $209K | Hold |
2,491
| – | – | 0.05% | 178 |
|
|
2016
Q4 | $183K | Hold |
2,491
| – | – | 0.05% | 181 |
|
|
2016
Q3 | $199K | Sell |
2,491
-200
| -7% | -$16K | 0.06% | 166 |
|
|
2016
Q2 | $211K | Buy |
+2,691
| New | +$203K | 0.06% | 166 |
|
|
2016
Q1 | – | Sell |
-2,461
| Closed | -$207K | – | 184 |
|
|
2015
Q4 | $207K | Buy |
+2,461
| New | +$204K | 0.06% | 178 |
|
|
2015
Q3 | – | Sell |
-2,461
| Closed | -$205K | – | 194 |
|
|
2015
Q2 | $205K | Buy |
+2,461
| New | +$188K | 0.05% | 195 |
|
Other funds holding LLY
M&R Capital Management's LLY Position: Q3 2024 in Review
M&R Capital Management increased its Eli Lilly (LLY) stake by 2.5% in Q3 2024, buying an estimated $39.6K and bringing the position to 1,802 shares worth $1.6M. The position accounts for 0.35% of the portfolio, ranked #49.
M&R Capital Management first reported a position in LLY in Q2 2015 and has held it in 36 quarters since. 3,658 funds tracked by Wall St. Rank hold LLY as of Q3 2024.
- M&R Capital Management held 1,802 shares of Eli Lilly worth $1.6M as of Q3 2024.
- M&R Capital Management bought 44 Eli Lilly shares in Q3 2024, an estimated $39.6K.
- Eli Lilly made up 0.35% of M&R Capital Management's portfolio in Q3 2024, its #49 holding.
- M&R Capital Management first reported a position in Eli Lilly in Q2 2015 and has held it in 36 quarters since.
- 3,658 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.
Based on M&R Capital Management's 13F filing for Q3 2024, filed 2 Oct 2024.